For the first time, the Middle East Journal of Cancer (MEJC) received an Impact factor of 0.4
Dear researchers,
We are pleased to announce that the Middle East Journal of Cancer (MEJC) has been evaluated by Clarivate Analytics (ISI) for the first time and received an Impact Factor of 0.4. This report has been published in the 2022 Journal Citation Report (JCR) in June 2023.
We would like to thank the editorial team, reviewers, and authors for their contributions to the Middle East Journal of Cancer (MEJC).